Jane Lebkowski Insider Profile
4 Followers
Jane Lebkowski, SVP, Chief Scientific Officer at Geron, holds 476.00 shares in Asterias Biotherapeutics (Ticker: AST), holds 568.15K shares in Geron (Ticker: GERN).
Jane Lebkowski's Trading History
| ASTAsterias Biotherapeutics | Jun 07, 2017 | ― | Uninformative Sell | 22.45K | $449.82 | |
| GERNGeron | Jun 16, 2011 | SVP, Chief Scientific Officer | Informative Sell | 108.12K | $549.40K |
You May Also Like
Jane Lebkowski insider profile FAQ
What is the percentage of profitable transactions made by Jane Lebkowski?
The percentage of profitable transactions made by Jane Lebkowski is 75%.
What is the average return per transaction made by Jane Lebkowski?
The average return per transaction made by Jane Lebkowski is 22.30%.
What stocks does Jane Lebkowski hold?
Jane Lebkowski holds: GERN, AST stocks.
What was Jane Lebkowski’s latest transaction?
Jane Lebkowski’s latest transaction was an Uninformative Sell of $22.45K.
What was Jane Lebkowski's most profitable transaction?
Jane Lebkowski’s most profitable transaction was an Informative Sell of GERN stock on May 24, 2011. The return on the trade was 68.40%.
What is Jane Lebkowski's role in Geron?
Jane Lebkowski's role in Geron is SVP, Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
